Is there potential for repurposing statins as novel antimicrobials?
MetadataShow full item record
Copyright © 2016, American Society for Microbiology. All Rights Reserved.Statins are members of a class of pharmaceutical widely used to reduce high levels of serum cholesterol. In addition, statins have so-called "pleiotropic effects," which include inflammation reduction, immunomodulation, and antimicrobial effects. An increasing number of studies are emerging which detail the attenuation of bacterial growth and in vitro and in vivo virulence by statin treatment. In this review, we describe the current information available concerning the effects of statins on bacterial infections and provide insight regarding the potential use of these compounds as antimicrobial therapeutic agents.
Showing items related by title, author, creator and subject.
Kurniawan, Dede Indra (2007)Background. Muscle cramps are one of the adverse affects suffered by hypercholesterolemia patients who are treated with statins. Besides reducing cholesterol levels, statins also reduce coenzyme Q10 (CoQ10) blood levels. ...
Curran, R.; Bernaitis, N.; Davey, A.; Hattingh, H. Laetitia; McFarlan, A.; Ching, E.; Chong, T.; Ching Chi Keong, C.; Anoopkumar-Dukie, S. (2016)HMG-CoA reductase inhibitors (statins) are widely prescribed for dyslipidaemia with established benefits in reducing cardiovascular disease mortality and morbidity. Controversy remains surrounding statin use in low risk ...
Cost-Effectiveness of Optimizing Use of Statins in Australia: Using Outpatient Data From the REACH RegistryAdemi, Z.; Reid, Christopher; Hollingsworth, B.; Stoelwinder, J.; Steg, P.; Bhatt, D.; Vale, M.; Liew, D. (2011)Background: Although few cardiovascular registries report the costs of illness or cost-effectiveness of health interventions, such information is critical to inform the effective and cost-effective management of cardiovascular ...